Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollution | 7 | 2025 | 327 | 1.870 |
Why?
|
| Particulate Matter | 7 | 2026 | 347 | 1.550 |
Why?
|
| Models, Statistical | 2 | 2025 | 682 | 1.170 |
Why?
|
| Causality | 2 | 2025 | 126 | 1.060 |
Why?
|
| Biometry | 1 | 2025 | 68 | 0.900 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 324 | 0.730 |
Why?
|
| Environmental Exposure | 6 | 2026 | 594 | 0.700 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 348 | 0.670 |
Why?
|
| Air Pollutants | 6 | 2025 | 439 | 0.660 |
Why?
|
| Brain Ischemia | 1 | 2023 | 358 | 0.610 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 1327 | 0.550 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 1098 | 0.500 |
Why?
|
| Medicare | 5 | 2024 | 890 | 0.460 |
Why?
|
| Stroke | 2 | 2023 | 1260 | 0.440 |
Why?
|
| Research Design | 1 | 2021 | 1137 | 0.430 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2026 | 480 | 0.350 |
Why?
|
| Cardiovascular Diseases | 4 | 2026 | 2182 | 0.350 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2026 | 300 | 0.320 |
Why?
|
| Heart Failure | 1 | 2023 | 2331 | 0.310 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 2 | 2019 | 26 | 0.270 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2025 | 923 | 0.260 |
Why?
|
| United States | 12 | 2026 | 16051 | 0.250 |
Why?
|
| Aged | 15 | 2026 | 26001 | 0.250 |
Why?
|
| Thromboembolism | 1 | 2026 | 125 | 0.220 |
Why?
|
| Bias | 1 | 2025 | 202 | 0.210 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 47 | 0.210 |
Why?
|
| Data Interpretation, Statistical | 1 | 2025 | 372 | 0.200 |
Why?
|
| Humans | 25 | 2026 | 145307 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 2592 | 0.190 |
Why?
|
| Hypnotics and Sedatives | 1 | 2025 | 216 | 0.190 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 71 | 0.190 |
Why?
|
| Biguanides | 1 | 2022 | 10 | 0.190 |
Why?
|
| Pharmacists | 1 | 2025 | 240 | 0.180 |
Why?
|
| Selection Bias | 1 | 2022 | 38 | 0.180 |
Why?
|
| Environmental Monitoring | 1 | 2025 | 379 | 0.180 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2019 | 547 | 0.180 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 194 | 0.180 |
Why?
|
| Calibration | 1 | 2022 | 151 | 0.180 |
Why?
|
| Hospitalization | 4 | 2025 | 2443 | 0.180 |
Why?
|
| Poverty | 2 | 2023 | 530 | 0.180 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 743 | 0.170 |
Why?
|
| Taiwan | 3 | 2026 | 46 | 0.170 |
Why?
|
| Entropy | 1 | 2021 | 45 | 0.170 |
Why?
|
| Overweight | 1 | 2026 | 610 | 0.170 |
Why?
|
| Rural Population | 1 | 2026 | 657 | 0.170 |
Why?
|
| Social Class | 1 | 2023 | 268 | 0.170 |
Why?
|
| Temperature | 1 | 2024 | 683 | 0.170 |
Why?
|
| Computer Simulation | 1 | 2025 | 1026 | 0.160 |
Why?
|
| Food Assistance | 1 | 2021 | 34 | 0.160 |
Why?
|
| Probability | 1 | 2021 | 312 | 0.160 |
Why?
|
| Coronary Angiography | 2 | 2019 | 324 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 260 | 0.160 |
Why?
|
| Fruit | 1 | 2021 | 152 | 0.160 |
Why?
|
| Vegetables | 1 | 2021 | 170 | 0.150 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 282 | 0.150 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 85 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2024 | 477 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 1211 | 0.140 |
Why?
|
| Machine Learning | 2 | 2022 | 589 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2024 | 726 | 0.140 |
Why?
|
| Metformin | 1 | 2022 | 320 | 0.140 |
Why?
|
| Eating | 1 | 2021 | 392 | 0.140 |
Why?
|
| Retrospective Studies | 7 | 2026 | 17149 | 0.140 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2025 | 772 | 0.130 |
Why?
|
| Aged, 80 and over | 6 | 2026 | 8295 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 245 | 0.120 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 64 | 0.120 |
Why?
|
| Aspirin | 1 | 2019 | 401 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2019 | 409 | 0.110 |
Why?
|
| Male | 12 | 2026 | 72629 | 0.110 |
Why?
|
| Quality of Life | 2 | 2025 | 3197 | 0.110 |
Why?
|
| Female | 12 | 2026 | 78605 | 0.100 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2025 | 134 | 0.100 |
Why?
|
| Diet | 1 | 2021 | 1285 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 2329 | 0.090 |
Why?
|
| Hot Temperature | 2 | 2024 | 407 | 0.080 |
Why?
|
| HIV Infections | 1 | 2025 | 3158 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2026 | 1488 | 0.080 |
Why?
|
| Middle Aged | 8 | 2026 | 36021 | 0.080 |
Why?
|
| Weight Loss | 2 | 2026 | 838 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2026 | 5982 | 0.070 |
Why?
|
| Risk Factors | 4 | 2026 | 10816 | 0.070 |
Why?
|
| Hypoglycemic Agents | 3 | 2024 | 1391 | 0.070 |
Why?
|
| Incidence | 2 | 2025 | 2892 | 0.070 |
Why?
|
| Blood Glucose | 3 | 2022 | 2333 | 0.060 |
Why?
|
| Equivalence Trials as Topic | 1 | 2025 | 36 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 40627 | 0.050 |
Why?
|
| Melatonin | 1 | 2025 | 163 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2024 | 47 | 0.050 |
Why?
|
| Seasons | 1 | 2025 | 557 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 137 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2025 | 3686 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 610 | 0.040 |
Why?
|
| San Francisco | 1 | 2021 | 60 | 0.040 |
Why?
|
| Life Style | 1 | 2023 | 483 | 0.040 |
Why?
|
| Prevalence | 2 | 2019 | 2838 | 0.040 |
Why?
|
| Los Angeles | 1 | 2021 | 76 | 0.040 |
Why?
|
| Urban Health | 1 | 2021 | 96 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1328 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 38 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2024 | 810 | 0.040 |
Why?
|
| No-Reflow Phenomenon | 1 | 2017 | 7 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2026 | 2439 | 0.030 |
Why?
|
| Veterans Health | 1 | 2019 | 189 | 0.030 |
Why?
|
| Disease Progression | 1 | 2025 | 2855 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 64 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 1063 | 0.030 |
Why?
|
| Risk | 1 | 2019 | 912 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2017 | 134 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 529 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 498 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 967 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1747 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1077 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 11731 | 0.030 |
Why?
|
| Insulin | 1 | 2024 | 2507 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2017 | 1035 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 504 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 2119 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 3085 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 3339 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 2398 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 7186 | 0.010 |
Why?
|